GPT and hepatocellular carcinoma: A Korean study that examined HBeAg− patients with viral levels ≥2000 IU/mL and normal or mildly elevated ALTs (<2× ULN) reported a higher risk of HCC (HR = 1.76; 95% CI: 1.00–3.10; p = .05) compared to those treated (ALT ≥2× ULN).26